logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Allchin, Gary John
    Born in June 1959
    Individual (7 offsprings)
    Officer
    2021-11-26 ~ now
    OF - Director → CIF 0
    Mr Gary John Allchin
    Born in June 1959
    Individual (7 offsprings)
    Person with significant control
    2021-11-26 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

EPSOM THERAPIES LIMITED

Period: 2021-11-26 ~ now
Company number: 13767985
Registered name
EPSOM THERAPIES LIMITED - now
Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Par Value of Share
Class 1 ordinary share
12024-05-01 ~ 2025-04-30
Property, Plant & Equipment
2,746 GBP2025-04-30
2,082 GBP2024-04-30
Debtors
515 GBP2025-04-30
1,300 GBP2024-04-30
Cash at bank and in hand
17,920 GBP2025-04-30
17,477 GBP2024-04-30
Current Assets
18,435 GBP2025-04-30
18,777 GBP2024-04-30
Creditors
Current
19,610 GBP2025-04-30
20,431 GBP2024-04-30
Net Current Assets/Liabilities
-1,175 GBP2025-04-30
-1,654 GBP2024-04-30
Total Assets Less Current Liabilities
1,571 GBP2025-04-30
428 GBP2024-04-30
Net Assets/Liabilities
1,049 GBP2025-04-30
32 GBP2024-04-30
Equity
Called up share capital
1 GBP2025-04-30
1 GBP2024-04-30
Retained earnings (accumulated losses)
1,048 GBP2025-04-30
31 GBP2024-04-30
Equity
1,049 GBP2025-04-30
32 GBP2024-04-30
Average Number of Employees
12024-05-01 ~ 2025-04-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
5,375 GBP2025-04-30
3,487 GBP2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
2,629 GBP2025-04-30
1,405 GBP2024-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
1,224 GBP2024-05-01 ~ 2025-04-30
Property, Plant & Equipment
Plant and equipment
2,746 GBP2025-04-30
2,082 GBP2024-04-30
Other Debtors
Amounts falling due within one year, Current
515 GBP2025-04-30
1,300 GBP2024-04-30
Trade Creditors/Trade Payables
Current
674 GBP2025-04-30
266 GBP2024-04-30
Other Taxation & Social Security Payable
Current
312 GBP2025-04-30
2,343 GBP2024-04-30
Other Creditors
Current
18,624 GBP2025-04-30
17,822 GBP2024-04-30
Amounts set aside to cover potential liabilities or losses
Deferred taxation
522 GBP2025-04-30
396 GBP2024-04-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1 shares2025-04-30

  • EPSOM THERAPIES LIMITED
    Info
    Registered number 13767985
    21 Stafford Road, Croydon, Surrey CR0 4NG
    PRIVATE LIMITED COMPANY incorporated on 2021-11-26 (4 years 6 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-11-25
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.